- The company has a drug delivery technology platform with multiple uses.
- One is already commercialized for dental practices and produces cash flow for developing and commercializing other applications.
- Management is concentrating on the CompuFlo Epidural, and the device looks on the edge of a commercial breakthrough.
- The economic case for hospitals and insurance companies is compelling.
High-Risk, High-Reward Investors Should Love Milestone Scientific
November 20th, 2019 · No Comments